Blood Collection Devices Market by Product, Method, Material, Application, End-user

Description

List of Tables

[184 Pages Report] The Blood Collection Devices Market size was estimated at USD 7.63 billion in 2023 and expected to reach USD 8.15 billion in 2024, at a CAGR 7.32% to reach USD 12.52 billion by 2030.

Blood collection devices are specialized instruments used in the medical field to extract human blood for diagnostic purposes, treatment monitoring, blood donations, and research. These devices are designed to assure the safety, accuracy, and efficiency of the blood collection process. Blood collection devices are crucial in minimizing the risk of contamination, assuring the integrity of the blood sample, and reducing discomfort during the collection process. The increasing cases of blood-related disorders and chronic diseases globally drive the demand for blood tests, fueling the market's growth. In addition, rising healthcare investments from the private & public sectors boost innovation in the market. However, the surging incidence of blood collection device recall impacts the expansion of the market. Furthermore, innovations in blood collection methods and devices offer more efficient, less invasive, and safer options for blood collection, pushing the market forward.

KEY MARKET STATISTICS
Base Year [2023]	USD 7.63 billion
Estimated Year [2024]	USD 8.15 billion
Forecast Year [2030]	USD 12.52 billion
CAGR (%)	7.32%

Product: Ongoing advancements blood collection systems to facilitate a seamless collection process

Blood collection needles and holders are critical devices used for venipuncture procedures, enabling the safe and efficient extraction of blood samples from patients. These devices are specifically designed to minimize patient discomfort while ensuring the integrity of the blood sample for accurate diagnostic results. Blood collection systems encompass a wide range of devices, including vacuum tubes, syringes, and other accessories essential for blood draw procedures. These systems are designed to facilitate a seamless collection process, from puncture to storage, ensuring the safety and efficiency of blood handling. Advanced systems also incorporate features that reduce contamination risk and improve sample quality. Blood collection tubes are an indispensable part of the blood collection and analysis process. These tubes come in various types, each designed for specific tests or analyses, including chemical, hematological, and serological investigations. They may contain additives and anticoagulants that preserve the integrity of the blood sample and prevent clotting. Plasma blood tubes are specially designed tubes containing anticoagulants that prevent blood from clotting, making them essential for tests that require plasma samples. The plasma is isolated from the blood cells by centrifugation, and it is used for a variety of diagnostic tests, including hormone levels and viral load measurements. Serum tubes are designed to facilitate the collection of serum, which is the liquid portion of blood that remains after clotting has occurred. These tubes generally do not contain anticoagulants. Serum tubes are commonly used for biochemical analyses and disease screening, as they provide a clear liquid free from blood cells. Lancets are small, sharp instruments used for capillary blood sampling, typically from a fingertip, especially in diabetes management for glucose testing, as well as in other diagnostic tests requiring small amounts of blood. Designed for single use, these devices prioritize patient comfort and safety, featuring mechanisms to prevent accidental needlesticks and cross-contamination.

Application: Growing awareness about early diagnosis driving the innovations of blood collection devices

The diagnostic segment holds a significant portion of the market for blood collection devices. These devices are essential for accurate diagnosis and monitoring of various diseases and conditions. They facilitate the collection of blood samples in a safe, efficient manner, minimizing the risk of contamination. Blood collection devices are extensively used in laboratories, hospitals, and clinics for diagnostic purposes, including blood tests for disease detection, blood typing, and the measurement of blood components. Therapeutic applications of blood collection devices entail procedures that require blood withdrawal for treatment purposes. These include plasmapheresis, therapeutic phlebotomy, and blood donations. Blood collection devices in therapeutic applications are designed to collect blood and its components in larger volumes safely and efficiently. The therapeutic segment benefits from the rising demand for blood transfusions and blood components in the treatment of various diseases, such as anemia and cancer, and for patients undergoing surgeries.

Regional Insights

In the American region, the demand for blood collection devices remains high due to the strong presence of healthcare facilities and a robust regulatory framework ensuring safety and efficacy. Ongoing innovations have focused on enhancing the safety and comfort of blood collection processes. Investments are directed towards automation and integration of digital technologies in collection devices. Customer purchasing behavior emphasizes quality, reliability, and technological advancements. European Union countries have stringent regulations governing medical devices, including blood collection devices. The focus is on safety, precision, and minimizing the invasiveness of blood collection techniques. The European market is distinguished by high demand for devices that are environmentally sustainable and ergonomic. Research and investment in the EU aim to reduce the ecological footprint of disposable devices while maintaining their clinical efficacy. The Middle East has been witnessing substantial growth in the healthcare sector, with significant investments in hospital infrastructure and medical technology. The APAC's rapidly expanding healthcare sector is propelling the demand for blood collection devices. The countries across the region have implemented significant reforms in healthcare policies, thereby attracting investments in both domestic and international market players. Innovations are particularly focused on disposable and user-friendly devices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Collection Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Collection Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Collection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Avanos Medical, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Exelint International, Co., Fresenius SE & Co. KGaA, Greiner AG, Haemonetics Corporation, ICU Medical, Inc., ITL Health Group, Kawasumi Laboratories America, Inc., Lasany International, Medtronic PLC, Nipro Corporation, Qiagen N.V., Sarstedt AG & Co. KG, Sekisui Medical Co., Ltd., Siemens Healthineers AG, Terumo Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Collection Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Blood Collection Needles/Holders
- Blood Collection System
- Blood Collection Tubes
  - Plasma Blood Tubes
  - Serum Tubes

Lancet

Method
- Automated Blood Collection
- Manual Blood Collection

Material
- Glass
- Plastic
- Rubber
- Stainless Steel

Application
- Diagnostic
- Therapeutics

End-user
- Blood Donation Centers
- Diagnostic & Pathology Laboratory
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Bolivia
  - Brazil
  - Canada
  - Chile
  - Colombia
  - Mexico
  - Paraguay
  - Peru
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Ecuador
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Collection Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Collection Devices Market?

3. What are the technology trends and regulatory frameworks in the Blood Collection Devices Market?

4. What is the market share of the leading vendors in the Blood Collection Devices Market?

5. Which modes and strategic moves are suitable for entering the Blood Collection Devices Market?

Product Code: MRR-742BD517BE69

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising cases of accidents or trauma cases with need for complex surgeries
  - 5.1.1.2. Demand for blood components and blood donations
  - 5.1.1.3. Availability of custom-designed blood collection devices
- 5.1.2. Restraints
  - 5.1.2.1. Surging incidence of blood collection device recall
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in blood collection and sampling technologies
  - 5.1.3.2. Establishments of new blood testing laboratories worldwide
- 5.1.4. Challenges
  - 5.1.4.1. Improper design of blood collection devices and inaccuracy of results
5.2. Market Segmentation Analysis
- 5.2.1. Product: Ongoing advancements blood collection systems to facilitate a seamless collection process
- 5.2.2. Application: Growing awareness about early diagnosis driving the innovations of blood collection devices
5.3. Cumulative Impact of High Inflation
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Regulatory Framework Analysis
5.7. Client Customization

6. Blood Collection Devices Market, by Product

6.1. Introduction
6.2. Blood Collection Needles/Holders
6.3. Blood Collection System
6.4. Blood Collection Tubes
6.5. Lancet

7. Blood Collection Devices Market, by Method

7.1. Introduction
7.2. Automated Blood Collection
7.3. Manual Blood Collection

8. Blood Collection Devices Market, by Material

8.1. Introduction
8.2. Glass
8.3. Plastic
8.4. Rubber
8.5. Stainless Steel

9. Blood Collection Devices Market, by Application

9.1. Introduction
9.2. Diagnostic
9.3. Therapeutics

10. Blood Collection Devices Market, by End-user

10.1. Introduction
10.2. Blood Donation Centers
10.3. Diagnostic & Pathology Laboratory
10.4. Hospitals & Clinics

11. Americas Blood Collection Devices Market

11.1. Introduction
11.2. Argentina
11.3. Bolivia
11.4. Brazil
11.5. Canada
11.6. Chile
11.7. Colombia
11.8. Mexico
11.9. Paraguay
11.10. Peru
11.11. United States

12. Asia-Pacific Blood Collection Devices Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Blood Collection Devices Market

13.1. Introduction
13.2. Denmark
13.3. Ecuador
13.4. Egypt
13.5. Finland
13.6. France
13.7. Germany
13.8. Israel
13.9. Italy
13.10. Netherlands
13.11. Nigeria
13.12. Norway
13.13. Poland
13.14. Qatar
13.15. Russia
13.16. Saudi Arabia
13.17. South Africa
13.18. Spain
13.19. Sweden
13.20. Switzerland
13.21. Turkey
13.22. United Arab Emirates
13.23. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Nipro Innovates in Blood Collection with Introduction of a Novel Air-Free Design
- 14.3.2. BD Secures FDA 510(k) Clearance for Innovative Fingertip Blood Collection Device
- 14.3.3. BD's Introduction of Needle-Free Device to Enhance Patient Comfort
- 14.3.4. Aptar and Tasso's Alliance to Revolutionize Blood Collection with Digital Integration
- 14.3.5. FDA Grants Clearance to YourBio Health's Innovative Blood Collection Device, Enhancing Efficiency and Patient Experience
- 14.3.6. Capitainer Unveils Innovative Self-Sampling Blood Collection Kit, Elevating Diagnostic Efficiency
- 14.3.7. Babson College and BD's Strategic Alliance for Enhanced Accessibility and Efficiency in Healthcare
- 14.3.8. Owen Mumford's Unveils Innovative Blood Collection Devices Enhancing Safety and Efficiency
- 14.3.9. Introducing RNA Complete BCT Revolutionizing Blood Collection with Enhanced Cell-Free RNA and Extracellular Vesicle Preservation

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio